Musings from The Power List: Renee Aguiar-Lucander
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
False
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
November 13, 2026
1 min read
Fujifilm Cellular Dynamics’ Delara Motlagh discusses her path into cell and gene therapy, the challenges of scaling manufacturing, and the potential of iPSC technologies
November 12, 2026
5 min read
How next-generation biomarker strategies could improve patient stratification, strengthen clinical trials, and reduce the cost of drug development
November 10, 2026
14 min read
Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients
November 6, 2026
1 min read
Power List 2026 honoree Harold Keer traces oncology’s transformation – and considers what it will take to turn today’s “abundance of riches” into better patient outcomes
False
Affiliations:
Specialties:
Areas of Expertise: